WallStreetZenWallStreetZen

NASDAQ: INZY
Inozyme Pharma Inc Stock Ownership - Who owns Inozyme Pharma?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Inozyme Pharma Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Douglas A. TrecoCEO Chairman2025-04-028,819$0.89
$7.85kSell
Sanjay SubramanianSVP CFO Head of BD2025-03-312,490$0.77
$1.92kBuy
Matthew WintonCOO2025-03-312,490$0.77
$1.92kBuy
Douglas A. TrecoCEO2024-09-301,710$4.45
$7.61kBuy
Matthew WintonCOO2024-09-301,710$4.45
$7.61kBuy

1 of 1

INZY insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when INZY insiders and whales buy or sell their stock.

INZY Shareholders

What type of owners hold Inozyme Pharma Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Robert Lorne Hopfner11.59%7,446,481$7.89MInsider
Adage Capital Partners GP LLC8.03%5,160,000$5.47MInstitution
Pivotal Bioventure Partners Investment Advisor LLC7.00%4,494,851$4.76MInstitution
Sofinnova Investments Inc6.66%4,280,308$4.54MInstitution
Longitude Capital Partners III LLC6.50%4,174,379$4.42MInsider
Affinity Asset Advisors LLC6.18%3,972,318$4.21MInstitution
Rock Springs Capital Management LP6.01%3,861,983$4.09MInstitution
Blackrock Inc5.93%3,812,539$4.04MInstitution
Pivotal Bioventure Partners Fund I LP4.92%3,162,895$3.35MInsider
Vanguard Group Inc4.10%2,633,249$2.79MInstitution

1 of 3

INZY vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
INZY55.76%44.24%Net SellingNet Selling
CBUS20.30%79.70%Net BuyingNet Selling
MNOV10.67%89.10%
AGEN5.93%94.07%Net BuyingNet Buying
SAVA33.12%66.88%Net Selling
View Top Biotech Stocks

Inozyme Pharma Stock Ownership FAQ

Who owns Inozyme Pharma?

Inozyme Pharma (NASDAQ: INZY) is owned by 81.56% institutional shareholders, 64.71% Inozyme Pharma insiders, and 0.00% retail investors. Robert Lorne Hopfner is the largest individual Inozyme Pharma shareholder, owning 7.45M shares representing 11.59% of the company. Robert Lorne Hopfner's Inozyme Pharma shares are currently valued at $8.56M.

If you're new to stock investing, here's how to buy Inozyme Pharma stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.